BBH Fees and Costs — VanEck Biotech ETF
Data updated: 2026-08-26
The net expense ratio is 0.35%. There are no sales loads or redemption fees. In fiscal 2025 the fund paid $49K in broker commissions, 0.0130% of average net assets, and portfolio turnover was 19%.
BBH Fees and Expenses
Annual operating expenses and sales charges of BBH. Prospectus, as of February 1, 2026.
| Annual operating expenses | |
|---|---|
| Management fee | 0.35% |
| 12b-1 fee | — |
| Other expenses | 0.00% |
| Gross expense ratio | 0.35% |
| Fee waiver | — |
| Net expense ratio | 0.35% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | No |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
BBH Costs Over Time
On $10,000 invested in BBH, assuming 5% a year before costs, total costs come to $230 over 5 years, cutting the return by 0.38% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.35%) | $37 | $115 | $202 |
| Trading costs (broker commissions) | $1 | $4 | $7 |
| Lost growth on money paid in costs | $0 | $6 | $21 |
| Total costs | $38 | $126 | $230 |
| Value after costs | $10,462 | $11,451 | $12,533 |
| Impact on return, per year | 0.38% | 0.38% | 0.38% |
BBH Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending September 30, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.0130%
- Total broker commissions: $49K
- Bought from dealers (principal trades, not a cost): $179.5M
- Portfolio turnover (prospectus): 19%
- Securities on loan, average value: $12.9M
- Net income from securities lending: $15K (0.004% of average net assets)
BBH Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Goldman Sachs & Co. LLC | $21K | 42.06% |
| Jefferies LLC | $14K | 27.53% |
| J.P. Morgan Securities LLC | $7K | 15.00% |
| UBS Securities LLC | $7K | 14.50% |
| Robert W. Baird & Co. Incorporated | $447 | 0.91% |
BBH Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| National Securities Clearing Corporation | $179.5M | 100.00% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.